Convertible Preferred Stock and Stockholders' Equity (Details)
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
Sep. 19, 2022
shares
|
Sep. 13, 2022
USD ($)
|
Aug. 15, 2022
USD ($)
$ / shares
shares
|
Dec. 30, 2021
USD ($)
|
Sep. 13, 2021
USD ($)
D
shares
|
Jun. 04, 2021
USD ($)
shares
|
Apr. 18, 2019
USD ($)
$ / shares
shares
|
Aug. 31, 2022
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Jun. 30, 2021
USD ($)
$ / shares
shares
|
Jan. 31, 2021
USD ($)
$ / shares
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
shares
|
Jun. 30, 2021
$ / shares
shares
|
Mar. 31, 2021
USD ($)
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
shares
|
Dec. 31, 2021
$ / shares
shares
|
Aug. 24, 2022
USD ($)
|
Aug. 19, 2022
shares
|
Jun. 21, 2022
shares
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
8.00%
|
|
|
|
Number of shares authorized |
|
|
|
|
|
|
|
|
1,250,000
|
|
|
0
|
|
|
|
0
|
|
1,250,000
|
|
|
|
Preferred stock outstanding |
|
|
|
|
|
|
|
|
0
|
|
|
0
|
|
|
|
0
|
|
0
|
|
|
|
Number of stock released |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
204,384
|
|
|
|
|
|
Stock-based compensation | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 63,000
|
|
|
|
$ 191,000
|
|
|
|
|
|
Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
290,625
|
|
|
|
290,625
|
|
|
|
|
|
Gross proceeds | $ |
|
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered direct offering, net of issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,026,000
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liability | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 274,000
|
$ 0
|
|
|
$ 274,000
|
$ 0
|
|
|
|
|
Common Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon warrant exchanged |
|
|
|
|
|
|
|
|
|
|
|
|
19,000
|
1,360,244
|
2,086,251
|
|
|
|
|
|
|
Registered direct offering, net of issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
Aggregate shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
|
|
|
Common Shares [Member] | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.50
|
|
|
|
$ 4.50
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.46
|
|
|
|
$ 4.46
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Gross proceeds | $ |
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
|
|
January 2021 | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 3.85
|
|
|
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
|
|
|
|
|
|
|
|
1,221,675
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 4.20
|
|
|
|
|
|
|
|
|
|
|
Warrant term |
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
$ 2,900,000
|
|
|
|
|
|
|
|
|
|
|
Vesting upon achievement of first milestone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization | $ |
|
|
|
|
$ 75,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 50,000,000
|
|
|
Vesting upon achievement of second milestone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization | $ |
|
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000,000
|
|
|
Vesting upon achievement of third milestone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization | $ |
|
|
|
|
$ 150,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000,000
|
|
|
Restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of restricted shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,274,900
|
|
|
|
|
|
Number of stock released |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
284,299
|
|
|
|
|
|
Shares unvested |
|
|
|
|
|
|
|
|
728,255
|
|
|
1,677,484
|
|
|
|
1,677,484
|
|
728,255
|
|
|
|
Unamortized compensation costs | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 2,374,000
|
|
|
|
$ 2,374,000
|
|
|
|
|
|
Weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 2 months 12 days
|
|
|
|
|
|
Carve-Out Plan | Restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate intrinsic value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000
|
|
|
|
|
|
|
Number of stock released |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
352
|
|
|
|
|
|
|
LTSI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum shares authorized to issue, percentage |
|
|
|
|
|
|
|
|
|
|
|
15.00%
|
|
|
|
15.00%
|
|
|
|
|
|
Percentage of maximum shares issued in a year |
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
8
|
|
|
|
|
|
Number of restricted shares granted |
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares available for grant |
|
|
|
|
|
|
|
|
|
|
|
1,265,525
|
|
|
|
1,265,525
|
|
|
|
|
|
LTSI | Restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of restricted shares granted |
|
|
|
|
|
|
|
|
|
|
|
61,348
|
29,064
|
|
|
284,299
|
29,064
|
|
|
|
|
Aggregate intrinsic value | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 37,000
|
$ 93,000
|
|
|
$ 294,000
|
$ 93,000
|
|
|
|
|
September 2021 Inducement Grant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized tax benefits, interest on income taxes expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 504,000
|
|
|
|
|
|
Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
Number of stock released |
|
|
|
|
232,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consecutive days to calculate volume weighted average closing price per share | D |
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 2021 Inducement Grant | Vest monthly over a period of 36 months |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting term |
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of stock released |
|
|
|
|
77,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of grant | $ |
|
|
|
|
$ 772,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 2021 Inducement Grant | Vest upon the achievement of certain company milestones |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of stock released |
|
|
|
|
77,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 2021 Inducement Grant | Restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of restricted shares granted |
|
|
|
|
310,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 Stock Incentive Plan | Restricted stock units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate intrinsic value | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 43,000
|
$ 646,000
|
|
|
$ 50,000
|
$ 646,000
|
|
|
|
|
Number of stock released |
|
|
|
|
|
|
|
|
|
|
|
59,931
|
201,343
|
|
|
66,766
|
201,343
|
|
|
|
|
Shares unvested |
|
|
|
|
|
|
|
|
438,462
|
|
|
361,627
|
|
|
|
361,627
|
|
438,462
|
|
|
|
Unamortized compensation costs | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 451,000
|
|
|
|
$ 451,000
|
|
|
|
|
|
Weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 months 24 days
|
|
|
|
|
|
2022 | Restricted stock units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of restricted shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
370,000
|
|
|
|
|
|
Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
370,000
|
|
|
|
370,000
|
|
|
|
|
|
Common stock authorized for issuance under the plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
500,000
|
Number of shares that each RSU represents |
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued to to employees, directors and consultants |
370,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unamortized compensation costs | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 191,000
|
|
|
|
$ 191,000
|
|
|
|
|
|
Weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years 8 months 12 days
|
|
|
|
|
|
Walsh |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
|
|
|
|
12,756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maxim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
194,384
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
$ 0.997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
$ 91,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price | $ / shares |
|
|
$ 0.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
80.30%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
2.91%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term |
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
194,384
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maxim | Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered direct offering, net of issuance costs | $ |
|
|
|
$ 4,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maxim | 2022 Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered direct offering, net of issuance costs | $ |
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lippert Heishorn Associates Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Price | $ / shares |
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
$ 1.52
|
|
|
|
|
|
|
|
|
1.52
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
$ 21,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
|
67.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
1.19%
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Design LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
$ 1.52
|
|
|
|
|
|
|
|
|
1.52
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
$ 12,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
Dividend rate |
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
|
67.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
1.19%
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
2,097,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
$ 0.997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
$ 985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price | $ / shares |
|
|
$ 0.77
|
|
|
|
|
|
|
|
|
$ 0.56
|
|
|
|
$ 0.56
|
|
|
|
|
|
Dividend rate |
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
Volatility rate |
|
|
80.30%
|
|
|
|
|
|
|
|
|
|
|
|
|
88.30%
|
|
|
|
|
|
Risk free interest rate |
|
|
2.91%
|
|
|
|
|
|
|
|
|
|
|
|
|
4.06%
|
|
|
|
|
|
Expected term |
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
2,097,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lisa Walsh |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock shares called by warrants issued |
|
|
|
|
|
187,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend | $ |
|
|
|
|
|
$ 1,192,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
Shares issued |
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
Stated value | $ / shares |
|
|
|
|
|
|
$ 4.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Floor price per share | $ / shares |
|
|
|
|
|
|
30.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares authorized |
|
|
|
|
|
|
|
1,250,000
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
Preferred stock outstanding |
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
Conversion price per share | $ / shares |
|
|
|
|
|
|
$ 80.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds net of issuance cost | $ |
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds net of issuance cost | $ |
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock | Walsh |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds net of issuance cost | $ |
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of embedded derivative liability | $ |
|
|
|
|
|
|
$ 216,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock | Lisa Walsh |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock issuable |
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock | Preferred Investor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock and Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued |
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par value | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|